Ivermectin's Post-Pandemic Resurgence: Promises and Perils in Cancer Treatment
Ivermectin, the controversial anti-parasitic drug, is making a comeback as an alternative cancer treatment, sparking renewed debates over its efficacy and safety.
Ivermectin, once a niche anti-parasitic drug, has found itself at the center of a firestorm in recent years. During the COVID-19 pandemic, the medication gained unexpected attention as some touted it as a potential treatment, despite a lack of scientific evidence. Now, as the pandemic recedes, Ivermectin is making a comeback, this time as an alternative treatment for cancer patients.
The renewed interest in Ivermectin as a cancer therapy stems from a growing body of research, albeit still inconclusive, suggesting the drug may have anti-tumor properties. Some studies have indicated that Ivermectin can inhibit the growth of certain types of cancer cells, such as those found in breast, prostate, and colon cancer.
Source: NPR
